HYPERTONIA ÉS NEPHROLOGIA - eLitMed.hu

40 MÁCSAI EMÍLIA ÉS MUNKATÁRSAI HYPERTONIA ÉS NEPHROLOGIA
8. Jones C, Holmes CJ, Krediet RT, et al Bicarbonate/Lactate Study Group Bicarbonate/lactate- based peritoneal dialysis solution increases cancer
antigen125 and decreases hyaluronic acid levels. Kidney Int. 2001 Apr; 59(4):1529-1538.
9. CamciI C, Buyukberber S, Tarakcioglu M, et al. The effect of continuous peritoneal dialysis on serum CA125 levels. Eur J Gynaecol Oncol.
2002;23(5): 472-474.
10. Garcia H, Hernandez-Jaras J, Cruz C, Agramunt I, Calvo C, Cerrillo V. Short- and medium-term increase of CA125 in peritoneal effluent using a
neutral-pH solution.Perit Dial Int. 2003 Jul-Aug;23(4): 375-380.
11. Margetts PJ, Bonniaud P. Basic mechanisms and clinical implications of peritoneal fibrosis. Perit Dial Int. 2003 Nov-Dec; 23(6):530-541.
12. Xu ZG, Kim KS, Park HC, Choi KH, Lee HY, Han DS, Kang SW. High glucose activates the p38 MAPK pathway in cultured human peritoneal
mesothel cells. Kidney Int. 2003 Mar;63(3): 958-968.
13. Numata M, Nakayama M, Minura S, Kawakami M, Lindholm B, KawaguchiI Y. Association between an increased surface area of peritoneal
micovessels and a high peritoneal solute transport rate. Perit Dial Int. 2003 Mar-Apr; 23(2):116-122.
14. Chung SH, Heimburger O, Steinvinkel P, Wang T, Lindholm B. Influence of peritoneal transport rate, inflammation, and fluid removal on
nutricional status and clinical outcome in prevalent peritoneal dialysis patients Perit Dial Int. 2003 Mar-Apr; 23(2): 174-183.
15. Liberek T, Lichodzijewska-Niemierko M, Knopinska-Posluszny W, et al. Generation of TNFalpha and interleukin-6 by peritoneal macrophages
after overnight dwells with bicarbonate- or lactate buffered dialysis fluid .Perit Dial Int. 2002 Nov-Dec; 22(6):663-669.
16. Williams JD, Craig KJ, Topley N, Williams GT.Peritoneal dialysis: changes to the structure of the peritoneal membrane and potential for
biocompatible solutions. Kidney Int Suppl. 2003 May; (84): S158-161.
17. Mortier S, De Vriese AS, Mcloughlin RM, et al. Effects of conventional and new peritoneal dialysis fluids on leukocyte recruitment in the rat
peritoneal membrane. J Am Soc Nephrol. 2003 May;14(5): 1296-1306.
18. Miyata T, Jadoul M, Kurokawa K. Beta-2 microglobulin in renal disease. J Am Soc Nephrol.1998;9: 723-735.
19. Welten AG, Schalwijk CG, Terwee PM, Meijer S, Van Den Born J, Beelen RJ. Single
exposure of mesothelial cells to glucose degradation products (GDPs) yields early advanced glycation end-products(AGEs) and a
proinflammatory response Perit Dial Int. 2003 May-Jun;23(3): 213-221.
20. De Vriese AS, Flyvbjerg A, Mortier S, Tilton RG, Lameire NH.Inhibition of the interaction of AGE-RAGE prevents hyperglycaemia-induced fibrosis
of the peritoneal membrane. J Am Soc Nephrol.2003 Aug; 14(8):2109-2118.
21. Bammens B, Evenepoel P, Verbeke K, Vanrenterghem Y. Removal of middle molecules and protein- bound solutes by peritoneal dialysis and
relation with uraemic symptoms. Kidney Int. 2003 Dec;64(6):2238-2243.
22. Clark WR, Winchester JF. Middle molecules and small-molecular-weight proteins in ESRD: Properties and strategies for removal Adv Ren Repl
Ther. 2003 Oct;10(4):270-278.
23. Steinvinkel P, Pecoits-Filho R, Lindholm B. Leptin, ghrelin, and proinflammatory cytokines: Compounds with nuritional impact in chronic kidney
disease? Adv Ren Repl Ther. 2003 Oct; 10(4):332-345.